Search

Purpose Little is known about oncofertility practice in developing countries that usually suffer from a shortage of health services, especially those related to cancer care. Materials and Methods To learn more about oncofertility practice in developing countries, we generated a survey to explore the barriers and opportunities associated with oncofertility practice in five developing countries from Africa and Latin America within our Oncofertility Consortium Global Partners Network. Responses from Egypt, Tunisia, Brazil, Peru, and Panama were collected, reviewed, and discussed. Results Common barriers were identified by each country, including financial barriers (lack of insurance coverage and high out-of-pocket costs for patients), lack of awareness among providers and patients, cultural and religious constraints, and lack of funding to help to support oncofertility programs. Conclusion Despite barriers to care, many opportunities exist to grow the field of oncofertility in these five developing countries. It is important to continue to engage stakeholders in developing countries and use powerful networks in the United States and other developed countries to aid in the acceptance of oncofertility on a global level. [ABSTRACT FROM AUTHOR]

Purpose: Little is known about oncofertility practice in developing countries that usually suffer from a shortage of health services, especially those related to cancer care. Materials and Methods: To learn more about oncofertility practice in developing countries, we generated a survey to explore the barriers and opportunities associated with oncofertility practice in five developing countries from Africa and Latin America within our Oncofertility Consortium Global Partners Network. Responses from Egypt, Tunisia, Brazil, Peru, and Panama were collected, reviewed, and discussed. Results: Common barriers were identified by each country, including financial barriers (lack of insurance coverage and high out-of-pocket costs for patients), lack of awareness among providers and patients, cultural and religious constraints, and lack of funding to help to support oncofertility programs. Conclusion: Despite barriers to care, many opportunities exist to grow the field of oncofertility in these five developing countries. It is important to continue to engage stakeholders in developing countries and use powerful networks in the United States and other developed countries to aid in the acceptance of oncofertility on a global level. [ABSTRACT FROM AUTHOR]

Copyright of Pan African Medical Journal is the property of Pan African Medical Journal and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Introduction: With the improvements in ultrasound equipment as well as the easy access to quantitative beta-human chorionic gonadotropin (β-hCG), the timing of diagnosis of ectopic pregnancy has moved to the early part of the first trimester. Ectopic pregnancies of unusual location are encountered much less frequently, but are perhaps more morbid. The treatment of these unusual ectopic gestations may not be as common place as treatment of tubal pregnancies, but with early diagnosis and effective planning, their treatment can be equally as effective. Objective: Describing cases of uncommon ectopic pregnancies which were managed with ultrasound-guided local injection of KCl, followed by intramuscular injection of MTX if appropriate. Explaining the modalities of the conservative treatment and detailing the clinical biological and ultrasound monitoring. Methods: It's a retrospective study over a period of 3 years which included patients presenting an ectopic pregnancy on uncommon implantation site and whose treatment was conservative. The medical treatment consisted in injection of KCl in the gestational sac by ultrasound guidance when the pregnancy was scalable. Then we proceed to one or more intramuscular Methotrexate injections in order to complete the treatment. Results: During the study's period we collected 04 observations of unusual ectopic pregnancies treated medically. There was an interstitial pregnancy in 2 cases: a cervical pregnancy in one case and a cesarean scar pregnancy in the other case. The diagnosis was made by ultrasound in all cases and confirmed by MRI in 2 cases. (Details will be shown in the poster). The medium term at diagnosis was 6 weeks of amenorrhea. Pregnancies were evolving with heart activity in 2 cases. The average number of injection of MTX was 1.3. In all of our cases, ectopic pregnancies have been successfully managed without surgical intervention or anesthesia using ultrasoundguided puncture and injection of KCl. Conclusion: The use of advanced ultrasonography in combination with ultrasensitive serum b-hCG assays should lead to early diagnosis of such pregnancies. Early diagnosis and use of multiple modalities can reduce morbidity and mortality in cases of ectopic pregnancy with unusual location and they can be successfully managed without surgical intervention through local injection of KCl. [ABSTRACT FROM AUTHOR]

Objective: Twin anemia polycythemia sequence (TAPS) is caused by small placental vascular anastomoses leading to chronic anemia in the donor and polycythemia in the recipient. TAPS can result in severe fetal or neonatal hematologic complications, cerebral injury and perinatal death. The aim of this study is to ascertain the most relevant echographic signs that helps to make an early diagnosis so we can improve the outcome of this sparse complication. Methods: It's about two observations of patients treated in the department of gynecology and obstetrics of the Mongi Slim hospital Tunis in 2013. Results: The first case is about a 42 years old patient with one miscarriage, one childbirth, blood type O negative, actual pregnancy a spontaneous monochorionic according to the early first trimester echography, adressed at 31 SA for intra uterine death of one the twins and hydrops fetalis of the second. The second patient is aged of 28 years, first pregnancy hospitalized at 29 SA to explore an hydramnios accidently discovered.The ultrasound exam performed in our service showed for the first twin: no bladder and anamnios, for the second twin: a huge bladder with polyhydramnios. In this too cases, the blood flow in the MCA was superior to 1.5MoM. Furthermore ultrasound allowed the guidance for fetal transfusion. Conclusion: TAPS is fetal emergency. Ultrasound is the only mean for the diagnosis and for the fetal therapy. [ABSTRACT FROM AUTHOR]